← FDA DRUG APPROVALS

FDA ANDA · ANDA076869

METFORMIN HYDROCHLORIDE

Sponsor: ACTAVIS LABS FL INC

APPLICATION
ANDA076869
TYPE
ANDA
ORIGINAL APPROVAL
2005-04-12
LATEST ACTION
2019-02-26
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Prescription

Products

METFORMIN HYDROCHLORIDEPrescription
METFORMIN HYDROCHLORIDE 750MG · TABLET, EXTENDED RELEASE · ORAL

Approval history

2019-02-26Labeling · Supplement 26 · standardAP
2019-02-26Labeling · Supplement 24 · standardAP
2008-10-31Labeling · Supplement 11AP
2007-05-25Labeling · Supplement 4AP
2005-04-12OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →